Vanguard Institutional Target Retirement 2040 Fund Institutional Shares (VIRSX)

1 member of Congress has disclosed 6 trades in Vanguard Institutional Target Retirement 2040 Fund Institutional Shares (VIRSX) via STOCK Act filings. The most recent disclosure was a sale by Grace Meng on 20 September 2022. Aggregate disclosed activity totals roughly $123.5K in purchases and $207.5K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for VIRSX
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for VIRSX

5 transactions
Compliance: 0%
Grace Meng20 Sept 20226 Jun 2023SaleStock$100,001 - $250,000N/A
Grace Meng20 Sept 20226 Jun 2023SaleStock$15,001 - $50,000N/A
Grace Meng29 Dec 202128 Dec 2022PurchaseStock$1,001 - $15,000N/A
Grace Meng29 Dec 202114 May 2022PurchaseStock$1,001 - $15,000N/A
Grace Meng18 May 201815 May 2019PurchaseStock$15,001 - $50,000N/A

See every trade

Sign in free to see the full trade history for this stock.

Stock Overview

Market Data

Market Cap

$47.41B

Volume

0

Beta

1.32

P/E Ratio

0.00

Fundamentals

EPS

$0.00

Div. Yield

1.70%

Open

$30.89

Day Range

$30.89 – $30.89

Company Information

Sector
Financial Services
Industry
Asset Management
Exchange
NASDAQ · USD
Country
US
IPO Date
2019-01-02

This fund aims to provide both long-term capital growth and a steady stream of income, aligning with its current investment portfolio. It accomplishes this by allocating its assets across various Vanguard mutual funds, following an investment strateg...

No earnings data available for this stock.

Dividends

Dividend History

30 Dec 2020
Amount $0.5250

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about VIRSX

Which members of Congress have traded VIRSX?
1 member of Congress has disclosed 6 trade in Vanguard Institutional Target Retirement 2040 Fund Institutional Shares (VIRSX) under the STOCK Act: Grace Meng.
When was VIRSX most recently disclosed by Congress?
The most recent VIRSX disclosure was a sale by Grace Meng on 20 September 2022.
What is the total disclosed congressional trading volume for VIRSX?
Members of Congress have disclosed approximately $123.5K in VIRSX purchases and $207.5K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in VIRSX?
This VIRSX page updates as soon as new STOCK Act disclosures are filed for Vanguard Institutional Target Retirement 2040 Fund Institutional Shares. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.